Compounds

Details Compounds Compounds

2007-06-13

2010-12-21

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S333000

Reexamination Certificate

active

07855213

ABSTRACT:
This invention relates to novel compounds having the structural formula I below:and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

REFERENCES:
patent: 4605642 (1986-08-01), Rivier et al.
patent: 5063245 (1991-11-01), Abreu et al.
patent: 5877399 (1999-03-01), Hsiao et al.
patent: 5942400 (1999-08-01), Anderson et al.
patent: 6211235 (2001-04-01), Wu et al.
patent: 6221667 (2001-04-01), Reiner et al.
patent: 6245884 (2001-06-01), Hook
patent: 6245964 (2001-06-01), McLonlogue et al.
patent: 7629356 (2009-12-01), Chessari et al.
patent: 2005/0282825 (2005-12-01), Malamas et al.
patent: 2005/0282826 (2005-12-01), Malamas et al.
patent: 2006/0281729 (2006-12-01), Iserloh et al.
patent: 2006/0287294 (2006-12-01), Zhu et al.
patent: 2007/0004730 (2007-01-01), Zhou et al.
patent: 2007/0004786 (2007-01-01), Malamas et al.
patent: 2007/0049589 (2007-03-01), Thompson, III et al.
patent: 2007/0099875 (2007-05-01), Zhu et al.
patent: 2007/0099898 (2007-05-01), Zhu et al.
patent: 2008/0287462 (2008-11-01), Chessari et al.
patent: 686673 (1995-06-01), None
patent: 742217 (1996-05-01), None
patent: 0855444 (1998-07-01), None
patent: 9534563 (1995-12-01), None
patent: 99/11643 (1999-03-01), None
patent: 0017369 (2000-03-01), None
patent: 0047618 (2000-08-01), None
patent: 0058479 (2000-10-01), None
patent: 0077030 (2000-12-01), None
patent: 0100663 (2001-01-01), None
patent: 0100665 (2001-01-01), None
patent: 0123533 (2001-04-01), None
patent: 0129563 (2001-04-01), None
patent: 0202505 (2002-01-01), None
patent: 0202506 (2002-01-01), None
patent: 0202512 (2002-01-01), None
patent: 0202518 (2002-01-01), None
patent: 0202520 (2002-01-01), None
patent: 0214264 (2002-02-01), None
patent: 0225276 (2002-03-01), None
patent: 2005058311 (2005-06-01), None
patent: 2005097767 (2005-10-01), None
patent: 2005123672 (2005-12-01), None
patent: 2006009655 (2006-01-01), None
patent: 2006/020879 (2006-02-01), None
patent: 2006034419 (2006-03-01), None
patent: 2006041404 (2006-04-01), None
patent: 2006041405 (2006-04-01), None
patent: 2006065204 (2006-06-01), None
patent: 2006065277 (2006-06-01), None
patent: 2006/076284 (2006-07-01), None
patent: 2006/099379 (2006-09-01), None
patent: 2006/138217 (2006-12-01), None
patent: 2006/138264 (2006-12-01), None
patent: 2006/138265 (2006-12-01), None
patent: 2006/138266 (2006-12-01), None
patent: 2006138230 (2006-12-01), None
patent: 2007/011810 (2007-01-01), None
patent: 2007011833 (2007-01-01), None
patent: 2007/049532 (2007-05-01), None
patent: 2007/058602 (2007-05-01), None
patent: 2007058580 (2007-05-01), None
patent: 2007058581 (2007-05-01), None
patent: 2007058582 (2007-05-01), None
patent: 2007058583 (2007-05-01), None
patent: 2007058601 (2007-05-01), None
patent: 2007058602 (2007-05-01), None
patent: 20007073284 (2007-06-01), None
patent: 2007114771 (2007-10-01), None
patent: 2007120096 (2007-10-01), None
patent: 2007/146225 (2007-12-01), None
patent: 2007/149033 (2007-12-01), None
patent: 2007145568 (2007-12-01), None
patent: 2007145569 (2007-12-01), None
patent: 2007145570 (2007-12-01), None
patent: 2007145571 (2007-12-01), None
patent: 2008063114 (2008-05-01), None
patent: 2008076043 (2008-06-01), None
patent: 2008076044 (2008-06-01), None
patent: 2008076045 (2008-06-01), None
patent: 2008076046 (2008-06-01), None
patent: 2008150217 (2008-12-01), None
patent: 2009005470 (2009-01-01), None
patent: 2009005471 (2009-01-01), None
patent: 2010056194 (2010-05-01), None
patent: 2010056195 (2010-05-01), None
patent: 2010056196 (2010-05-01), None
Vippagunta et al., Crystalline solids, 2001, Advanced Drug Delivery Reviews, 48, pp. 3 and 18.
Von Angerer, S. “Product class 12: pyrimidines”, Science of Synthesis, 2004, 16, 379-572.
Blanchard, Barbara; PNAS, Oct. 2004, 101 (40), 14326-14332.
Barrett, P et al, J. Chem. Soc., 1939, 1809-20.
Bartlett, R et al, J. Chem. Soc. Section C., 1969, 1, 129-33.
Sawanishi et al, Chemical & Pharmaceutical Bulletin, 1985, 33 (10), 4564-71.
Siling, S et al, Doklady Akademii Nauk SSSR, 1988, 299 (3), 633-5.
De Strooper, Bart et al., A Firm Base for Drug Development, Dec. 1999, Nature 402, 1999, 471-472.
Yankner B A., New Clues to Alzheimer's Disease: Unraveling the Roles of Anyloid and Tau, Nature Medicine, 1996, 2(8), 850-852.
Office action dated Mar. 19, 2009 received in co pending U.S. Appl. No. 12/120,736.
Dorwald F. Z. Side Reactions in Organic Synthesis, A Guide to Successful Synthesis Design, Weinheim: Wiley-VCH Verlag GmBH & Co, KgaA, 2005, Preface.
Hussain et al., 1999, Mol Cell Neurosci. Dec 14(6), 419-427.
Jordan V. C., Nature Reviews, Mar. 2, 2003: 205-213.
Lin et. al, 2000, PNAS, 97(4), 1456-1460.
Owens M.J., Pharm Rev vol. 43, pp. 425-473 (1991).
Oyama et al., 1994, J Neurochem, 62(3), 1062-1066.
Sinha et. al., 1999, Nature 402(6761), 537-540.
Vassar et. al., 1999, Science, 286(5440), 735-741.
Vippagunta et al. Crystalline Solids, 2001, Advanced Drug Delivery Reviews, 48, pp. 3 and 18.
Yan et. al, 1999, Nature 402(6761), 533-537.
Yankner, 1996, Nature Medicine, 2(8), 850-852.
U.S. Appl. No. 12/618,088 dated 2009.
U.S. Appl. No. 12/618,114 dated 2009.
U.S. Appl. No. 12/618,212 dated 2009.

Affiliated with

Also associated with

Rating

Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4152076